112 related articles for article (PubMed ID: 35851967)
1. Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.
Knight JC; Cornelissen B
Am J Nucl Med Mol Imaging; 2014; 4(2):96-113. PubMed ID: 24753979
[TBL] [Abstract][Full Text] [Related]
2. Sulfonyl Diazaborine 'Click' Chemistry Enables Rapid and Efficient Bioorthogonal Labeling.
Chowdhury A; Chatterjee S; Kushwaha A; Nanda S; Dhilip Kumar TJ; Bandyopadhyay A
Chemistry; 2023 Jul; 29(41):e202300393. PubMed ID: 37155600
[TBL] [Abstract][Full Text] [Related]
3. Durable Attenuation of Tumor pH-Platelet Linkage Reinstates Bioorthogonal Targeting of Residual Tumors Post-Debulking.
Zhang P; Li B; Wang Z; Li J; Wang F; Kong J; Zhou Z; Huang Y; Li L
ACS Nano; 2024 Feb; 18(5):4520-4538. PubMed ID: 38270077
[TBL] [Abstract][Full Text] [Related]
4. Intrahippocampal Supramolecular Assemblies Directed Bioorthogonal Liberation of Neurotransmitters to Suppress Seizures in Freely Moving Mice.
Wu C; Xie J; Yao Q; Song Y; Yang G; Zhao J; Zhang R; Wang T; Jiang X; Cai X; Gao Y
Adv Mater; 2024 Apr; ():e2314310. PubMed ID: 38655719
[TBL] [Abstract][Full Text] [Related]
5. Cancer's sweet spot: techniques to harness saccharides in tumor biology.
Parker J
Biotechniques; 2024 Jan; 76(1):5-8. PubMed ID: 38047326
[TBL] [Abstract][Full Text] [Related]
6. Daily briefing: Nobel for click and bioorthogonal chemistry.
Graham F
Nature; 2022 Oct; ():. PubMed ID: 36203056
[No Abstract] [Full Text] [Related]
7. Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.
Bohrmann L; Poulie CBM; Rodríguez-Rodríguez C; Karagiozov S; Saatchi K; Herth MM; Häfeli UO
PLoS One; 2024; 19(4):e0300466. PubMed ID: 38626058
[TBL] [Abstract][Full Text] [Related]
8. A narrative review: progress in transition metal-mediated bioorthogonal catalysis for the treatment of solid tumors.
Wan X; Zhang Y; Nie Y; Zhang K; Jin Z; Zhang Z; Gan L; Liu X; He J
Transl Cancer Res; 2023 Aug; 12(8):2181-2196. PubMed ID: 37701121
[TBL] [Abstract][Full Text] [Related]
9. Click Triazole as a Linker for Pretargeting Strategies: Synthesis, Docking Investigations, Fluorescence Diagnosis, and Antibacterial Action Studies.
Liu Q; Zhao M; Song C; Sun J; Tao J; Sun B; Jiang J
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985730
[TBL] [Abstract][Full Text] [Related]
10. Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted
Stéen EJL; Jørgensen JT; Denk C; Battisti UM; Nørregaard K; Edem PE; Bratteby K; Shalgunov V; Wilkovitsch M; Svatunek D; Poulie CBM; Hvass L; Simón M; Wanek T; Rossin R; Robillard M; Kristensen JL; Mikula H; Kjaer A; Herth MM
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):824-833. PubMed ID: 33860205
[TBL] [Abstract][Full Text] [Related]
11. Bioorthogonal "Click and Release" Reaction-Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy.
Yan X; Li K; Xie TQ; Jin XK; Zhang C; Li QR; Feng J; Liu CJ; Zhang XZ
Angew Chem Int Ed Engl; 2024 Mar; 63(13):e202318539. PubMed ID: 38303647
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging.
García-Vázquez R; Battisti UM; Herth MM
Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745604
[TBL] [Abstract][Full Text] [Related]
13. Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy.
Rondon A; Degoul F
Bioconjug Chem; 2020 Feb; 31(2):159-173. PubMed ID: 31855602
[TBL] [Abstract][Full Text] [Related]
14. Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo.
Poulie CBM; Sporer E; Hvass L; Jørgensen JT; Kempen PJ; Lopes van den Broek SI; Shalgunov V; Kjaer A; Jensen AI; Herth MM
Chemistry; 2022 Nov; 28(61):e202201847. PubMed ID: 35851967
[TBL] [Abstract][Full Text] [Related]
15. Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer.
Hapuarachchige S; Huang CT; Donnelly MC; Bařinka C; Lupold SE; Pomper MG; Artemov D
Mol Pharm; 2020 Jan; 17(1):98-108. PubMed ID: 31840521
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
